Ticker Details
Oric Pharmaceuticals, Inc.
IPO Date:	April 24, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.47B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.47 | 3.86%
Avg Daily Range (30 D):	$0.43 | 3.69%
Avg Daily Range (90 D):	$0.31 | 2.98%

Institutional Daily Volume
Avg Daily Volume:	.54M
Avg Daily Volume (30 D):	1.3M
Avg Daily Volume (90 D):	1.33M

Trade Size
Avg Trade Size (Sh.):	85
Avg Trade Size (Sh.) (30 D):	71
Avg Trade Size (Sh.) (90 D):	73

Institutional Trades
Total Institutional Trades:	1,290
Avg Institutional Trade:	$1.68M
Avg Institutional Trade (30 D):	$1.84M
Avg Institutional Trade (90 D):	$1.75M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.94M
Avg Closing Trade (30 D):	$2.37M
Avg Closing Trade (90 D):	$2.38M
Avg Closing Volume:	172.67K

News

Aug 7, 2026 @ 8:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Na

May 12, 2026 @ 9:41 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Apr 3, 2026 @ 8:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc.

Apr 1, 2026 @ 6:48 AM ORIC Pharmaceuticals Stock Nosedives 25% After Hou... Source: Tanya Rawat

Jan 14, 2026 @ 3:52 PM Precision Killers: Why Big Pharma is Betting Billi... Source: Prnewswire

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.32	$-.38	$-.34
Diluted EPS	$-1.32	$-.38	$-.34
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-140.35M	$-41.49M	$-35.77M
Operating Income / Loss	$-156.14M	$-45.3M	$-39.62M
Cost of Revenue
Net Cash Flow	$-38.38M	$-18.91M	$10.73M
PE Ratio